byettaPancreatic Disease Risk Increased by Type 2 Diabetes Drug Byetta
Byetta, a drug commonly prescribed for the treatment of type 2 (adult onset) diabetes, has been linked to an increased risk of deadly pancreatic disease. Dozens of Byetta patients have suffered a painful injury called hemorrhagic pancreatitis, or inflammation of the pancreas, that resulted in death or serious injuries. The Food and Drug Administration has issued several public advisories about Byetta’s connection to pancreatic disease and warned users about the risk.
More Deaths Linked to Type 2 Diabetes Drug Byetta
One week after the Type 2 diabetes drug Byetta was named a factor in the deaths of two patients, the drug makers have confirmed the deaths of four more people who had been taking the drug. Byetta, made by Eli Lilly and Amylin Pharmaceuticals, has been linked to acute pancreatitis, which can result in nausea, vomiting, abdominal pain, and other symptoms. The four most recent patient deaths, revealed on August 26, 2008, were caused by a milder form of pancreatitis …
Diabetes Medication Byetta Linked to Pancreatitis, FDA Orders Stronger Label Warning
Byetta, a Type 2 diabetes drug made by Amylin Pharmaceuticals, Inc., has been linked to six cases of hemorrhagic or necrotizing pancreatitis. Two patients have died and four others are recovering after being hospitalized, according to the U.S. Food and Drug Administration. The recent incidents have prompted the FDA to develop stronger, more prominent warnings for the product’s label to alert consumers about the risk of acute hemorrhagic or necrotizing pancreatitis. Physicians are being cautioned to consider anti-diabetic therapies other …
facebook
rss
twitter